NCT00593593View on ClinicalTrials.gov

Pharmacovigilance Study To Evaluate Safety Of AVODART In Subjects With Benign Prostate Hyperplasia

CompletedOBSERVATIONAL
Enrollment

1,000

Participants

Timeline

Start Date

December 31, 2004

Conditions
Benign Prostatic Hyperplasia
Sponsors

Lead Sponsor

GlaxoSmithKline
All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY